RESUMEN
The development of antimicrobial resistance in main pathogens of respiratory system infections (S. pneumoniae, H. Influenzae, B. catarrhalis) reduces the range of unprotected penicillins indications. The inhibitors of beta-lactamase rendered back the original spectrum of antimicrobial activity to aminopenicillins and ureidopenicillins, and withheld them within the most frequently used armamentarium of antimicrobial drugs for the therapy of more severe infections. The prescription of penicillins is ruled according to the localization of infection, most frequent pathogens and by the epidemiologic situation. A combined antibiotic therapy is indicated in severe infections. An important indication area is the prophylactic administration of penicillins in recurring tonsilopharyngitis, recurring otitis media and eradication of meningococcal carriership. (Tab. 1, Ref. 3.).
Asunto(s)
Penicilinas/uso terapéutico , Infecciones del Sistema Respiratorio/tratamiento farmacológico , HumanosRESUMEN
The authors studied a relationship between particular bacterial or fungal organisms isolated from blood cultures and type of malignancy and antineoplastic drugs in 237 cancer patients. Sixty four had acute myelogenous leukemia (AML), 43 non-Hodgkin's lymphoma (NHL) and 140 solid tumors (ST). All patients had at least one positive blood cultures for one or more microorganism drawn during 1-10 days after cytotoxic chemotherapy, viridans streptococcal bacteremia was more frequently observed in patients with AML (12.5%) and NHL (27.9%) than ST (43%, p < 0.01 and 0.03). The incidence of anaerobic bacteria was similar in patients with NHL and ST, and in both groups significantly higher (p < 0.05) than in AML. Enterobacteriaceae caused bacteremia less frequently in patients with AML than in those with ST (12.5 vs 27.8%, p < 0.05). However, the highest incidence of Stenotrophomonas maltophilia bacteremia was seen in patients with AML (6.3% vs 2.3%, p < 0.04 and 0.03). Concerning fungemia, Candida albicans occurred significantly more frequently in blood cultures in patients with NHL, and molds in patients with AML. Cytarabine and metothrexate seems to be more frequently associated with viridans streptococci, cytarabine and mitoxanthrone with Stenotrophomonas maltophilia, B. fragilis with cisplatin and 5-fluorouracil, Fusarium spp., Mucorales and Aspergillus spp. with acute leukaemia (AL) treated with cytarabine and mitoxantrone. The association of other pathogens with an underlying disease or chemotherapeutic regimen could not be documented. (Tab. 1, Ref. 19.).
Asunto(s)
Antineoplásicos/uso terapéutico , Bacteriemia/microbiología , Neoplasias/complicaciones , Profilaxis Antibiótica , Bacteriemia/complicaciones , Bacteriemia/prevención & control , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/microbiologíaRESUMEN
Vancomycine serum levels were measured in 198 cancer patients with documented grampositive bacteremia and twenty two failed. Failures were analyzed for risk factors of therapy failure. Only 8 of 22 showed low serum peak or through vancomycin levels. One patient was treated less than 7 days, 9 had persisting and 4 catheter associated bacteremia. Bacteremias due to VAN resistant strains were excluded. In 14 out of 22 patients, multiple or one risk factor could be determined, but in 8 patients, no risk factor was found. Hence the, case control study was conducted to compare the group of failures in 22 patients with a group of patients with underlying disease and neutropenia treated successfully within the same period and same antibiotic policy at the same cancer center, by VAN for gram-positive bacteremia. Persisting, catheter associated and enterococcal bacteremias were the only statistical significant risk factors predicting a therapy failure in cancer patients. Neither Vancomycine serum peak nor through levels predicted the outcome: failure or cure of gram-positive bacteremia in cancer patients. (Tab. 1, Ref. 5.).